About
Investment Strategies

Growth Equity

Expansion capital for enterprise technology and healthcare companies across North America

Total Return

Opportunistic investments in traditional and alternative asset classes in pursuit of total return

Private Capital

Investing in private credit, special situations and private equity funds

Municipal Bonds

Customized fixed income investment solutions for individuals, trusts and estates

Social Impact

A new paradigm for Opportunity Zone investing

Team
News

Continue to Intralinks Portal

Navigate back to website

Investor Login
Contact
Home
About
Investment Strategies

Growth Equity

Expansion capital for technology-enabled businesses and healthcare companies across North America

Total Return

Opportunistic investments in traditional and alternative asset classes in pursuit of total return

Private Capital

Investing in private credit, special situations and private equity funds

Municipal Bonds

Customized fixed income investment solutions for individuals, trusts and estates

Social Impact

A new paradigm for Opportunity Zone investing

Team
News
Contact
Investor login

News

2/25/2015

An article in the journal Cancer Research indicates that Oncoceutics' ONC201 eradicates cancer stem cells in colorectal cancer

1/13/2015

Outrigger Media raises $5.2 million, adds YouTube demographics to OpenSlate

12/23/2014

Trimble acquires IRON Solutions to broaden its connected farm solution for growers, Ag dealers and agronomists

9/29/2014

Spring Mountain Capital leads investment in Oncoceutics

9/24/2014

Hurel Corporation completes investment from Johnston Associates, Inc.

8/5/2014

Spring Mountain Capital, LP Leads Investment in IsoPlexis Corporation

10/29/2013

Cisco completes acquisition of WhipTail

10/1/2013

Hurel enters into cell-based R&D collaboration with Sanofi US to validate HurelHuman in vitro liver tissue co-culture for use in pre-clinical drug development

9/10/2013

Cisco announces intent to acquire WhipTail for $415 million

7/16/2013

Hurel Corporation launches cell-based in vitro testing product suite, milestone in movement away from use of live animals in drug and toxicity testing

4/3/2013

Hurel receives $9.2 million Series A funding from Spring Mountain Capital

Previous
Copyright Ⓒ 2025 Spring Mountain Capital, LP. All rights reserved. | Terms of Use | Privacy Policy